Drug interaction study of leramistat in healthy adults
Treatments studied
This study tests how a drug called leramistat interacts with other medicines. It's for healthy adults who cannot get pregnant or make someone pregnant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Be in good general health (no serious medical or mental health conditions)
- Be unable to become pregnant or get someone pregnant (surgically sterile or postmenopausal for women, sterilized or using contraception for men)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how two other drugs affect the levels of the study drug pelabresib in healthy people. It aims to see if taking these drugs together changes how the body processes pelabresib.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.
This study tests how a common antifungal medication (itraconazole) affects how the body processes an experimental drug called nacresertib. Researchers want to understand if taking both drugs together is safe and how they interact in healthy volunteers.
This study checks if taking itraconazole, an antifungal medicine, changes how the body processes the investigational drug HS-10504. It helps researchers understand safe dosing and potential side effects.
This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.